US Stock MarketDetailed Quotes

ANIP ANI Pharmaceuticals

Watchlist
  • 55.010
  • +0.500+0.92%
Close Feb 26 16:00 ET
  • 55.800
  • +0.790+1.44%
Pre 06:37 ET
1.16BMarket Cap-117.04P/E (TTM)

ANI Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ANI Pharmaceuticals Q4 2024 Estimates Date

Currency：USDFeb 28, 2025

Estimate YoY
Revenue
175.35M
+33.19%
EPS
0.29
+633.25%
Analyst Rating
Buy

Feb 26, 2025

ANI Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 165.912M--
Feb 28, 20252024/Q4-- / 175.355M--
Nov 8, 20242024/Q3148.332M / 144.375M--
Aug 6, 20242024/Q2138.040M / 129.053M--
May 10, 20242024/Q1137.430M / 126.028M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 165.912M--
Feb 28, 20252024/Q4-- / 175.355M--
Nov 8, 20242024/Q3148.332M / 144.375M--
Aug 6, 20242024/Q2138.040M / 129.053M--
May 10, 20242024/Q1137.430M / 126.028M--

Unlock Free Earnings Estimates

ANI Pharmaceuticals Earnings Reports

  • ANI Pharmaceuticals | 8-K: ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

    Jan 13 07:29 ET

  • ANI Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 8, 2024 08:05 ET

  • ANI Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 07:03 ET

  • ANI Pharmaceuticals | 8-K: ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

    Aug 6, 2024 06:59 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +16.49%
    Hutchmed (China)
    HCM
    +6.29%
    Workday
    WDAY
    +6.22%
    DexCom
    DXCM
    +1.80%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +0.62%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 26, 2025

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data